Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronotherapy for cancer.

M Eriguchi1, F Levi, T Hisa

  • 1Incubation Project Cancer Metastasis, Department of Intellectual Property, Research Center for Advanced Science and Technology, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8904, Japan. eriguchi@ip.rcast.u-tokyo.ac.jp

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|October 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic syndrome and the risk of breast cancer in postmenopausal women.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

European cancer mortality predictions for the year 2011.

Annals of oncology : official journal of the European Society for Medical Oncology·2011
Same author

Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases.

The British journal of surgery·2011
Same author

Feasibility of cetuximab given with a simplified schedule every 2 weeks in advanced colorectal cancer: a multicenter, retrospective analysis.

Medical oncology (Northwood, London, England)·2010
Same author

Variation in performance in low-volume mammography screening programmes: experience from Switzerland.

Cancer epidemiology·2010
Same author

Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.

British journal of cancer·2010
Same journal

Corrigendum to 'A new perspective on targeting pulmonary arterial hypertension: Programmed cell death pathways (Autophagy, Pyroptosis, Ferroptosis)' [Biomed. Pharmacother. 181 (2024) 117706].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Comparative in vitro evaluation of fourth-generation anti-GPC3 CAR T-cells in hepatocellular carcinoma.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Inhibition of the ZEB1-BCL2 axis in cancer-associated fibroblasts as a strategy to improve chemotherapy response in intrahepatic cholangiocarcinoma.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

From DNA-encoded library (DEL) screening to in vivo validation: LILRB4 (ILT3)-targeted small molecules reprograms myeloid immune suppression.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Wnt activation during epileptogenesis prevents pathological immature dentate granule cell morphological changes in animal models of unilateral and bilateral temporal lobe epilepsy.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Protective effects of ACF210, a dual GLP-1/APJ receptor agonist, against cardiovascular-kidney-metabolic syndrome induced by T2D.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
See all related articles

Cancer chronotherapy optimizes drug timing based on circadian rhythms to enhance anti-cancer effects and reduce side effects. This approach shows promise for gastrointestinal and colorectal cancers, potentially improving survival rates.

Area of Science:

  • Chronobiology
  • Oncology
  • Pharmacology

Background:

  • Cancer chronotherapy leverages circadian rhythms for optimized drug delivery.
  • Biological rhythms are regulated by clock genes within the suprachiasmatic nucleus (SCN).

Purpose of the Study:

  • To explore the principles and clinical applications of cancer chronotherapy.
  • To highlight the potential of chronomodulated chemotherapy in cancer treatment.

Main Methods:

  • Administering anti-cancer drugs based on circadian rhythms of efficacy and toxicity.
  • Utilizing chronomodulated chemotherapy regimens, such as l-OHP + 5-FU + FA for colorectal cancer.

Main Results:

  • Successful treatment of advanced gastrointestinal cancer with chronomodulated chemotherapy.

Related Experiment Videos

  • Achieving complete surgical resection of liver metastases in colorectal cancer patients, leading to 39-50% 5-year survival.

    • Conclusions:

    • Cancer chronotherapy is a promising, logical therapeutic strategy.
    • Chronotherapy principles may extend beyond cancer treatment to other diseases.